Image-guided therapy
Ultra-low contrast PCI
Make low contrast a high priority for PCI procedures
With advanced Philips imaging and proven physiology technologies, learn how you can confidently treat PCI patients with less contrast.
Reduce need for contrast during PCI procedures to enhance patient care
During PCI procedures, angiograms aren't always accurate for diagnoses [1]. The contrast dye used in these tests can harm the kidneys, leading to contrast-induced nephropathy (CIN) and hospital-acquired acute kidney injury (AKI) [2]. The need to implement efficient workflows while delivering safe and effective treatment has never been greater.Ultra-low contrast PCI: A structured approach to Reducing Dependence on Contrast Vessel Opaification in PCI*
Philips offers an evolved solution of vascular imaging and physiology technologies
We provide clinicians with diagnostic and treatment options that not only optimize PCI procedures, but also reduce dependency on angiography and nephrotoxic imaging contrast.
Explore the broadest suite of integrated solutions for ultra-low contrast PCI procedures
- iFR Co-registration: As an alternative or adjunct to IVUS Co-registration, iFR pullback can be Co-registered onto the angiogram to assess both the degree and length of vessel stenosis.
- Dynamic Coronary Roadmap: This Philips-exclusive technology provides a real-time view of the coronary arteries and removes the need for additional contrast injections.
- StentBoost: This simple, quick and cost-effective tool enhances stent visualization in the coronary arteries.
Featured solutions for Ultra-low contrast PCI
CardiacSwing
A dual-axis rotational system allows you to see comprehensive views of the coronary anatomy, including views often hidden during conventional angiography.
IVUS
Intravascular ultrasound (IVUS) provides images from within the vessel to accurately assess and optimize your treatment plan.
IVUS Co-registration
Software helps you understand precisely where the disease begins and ends and guides your pre-and post-strategy decisions for improved outcomes.
Today’s advanced imaging and physiology technologies are enabling the delivery of precision PCI with much less imaging contrast than in the past, reducing the risk of AKI and opening the door to therapy in a group of patients commonly denied PCI.
Dr. Ziad Ali
St. Francis Hospital & Heart Center
Documentation
Footnotes
- https://www.philips.com/a-w/about/news/archive/standard/news/press/2020/20201015-define-pci-study-one-year-data-show-potential-of-treating-residual-ischemia-to-improve-clinical-outcomes-for-coronary-stent-patients.html
- Amin P, et al. Incremental cost of Acute Kidney Injury after Percutaneous Coronary Intervention in the United States. AM J Cardiol. 2020 Jan 1;125(1):29-331
Disclaimer
*Content in this manuscript is for informational purposes only. Always refer to the IFU for instructions on how to use products and important safety information. This review provides guidance on how to decrease dependence on contrast during PCI. Explore how the tools and techniques that constitute the ULCPCI toolkit may be incorporated into a structured approach to perform interventions with the lowest possible amount of contrast, facilitating the incorporation of ULCPCI into routine practice.
Always read the label and follow the directions for use.
Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device.
Products subject to country availability. Please contact your local sales representative.
©2025 Koniklijke Philips N.V. All rights reserved. Trademarks are the property of Koninklijke Philips N.V. or their respective owners. Philips reserves the right to change product specifications without prior notification.